Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Spectra7 Microsystems Inc. Provides Update on Previously Announced Short Form Prospectus Offering and Concurrent Private Placement; Total Gross Proceeds of $7.92 Million
-
MJ Innovation Capital Corp. Completes Initial Public Offering
-
Quanterix (QTRX) Prices 2.38M Share Common Stock Offering at $25.25/Sh
-
Quanterix Prices Public Offering of Common Stock
-
Canaccord Genuity Upgrades Cronos Group (CRON:CN) (CRON) to Hold
-
Canaccord Genuity Downgrades Coeur d'Alene Mines (CDE) to Hold
-
Canaccord Genuity Downgrades Fortuna Silver Mines (FVI:CN) (FSM) to Hold
-
Net Asset Value(s)
-
CarGurus to Present at Canaccord Genuity’s 39th Annual Growth Conference
-
CarGurus to Present at Canaccord Genuity’s 39th Annual Growth Conference
-
InMode Ltd. (INMD) Prices 5M Share IPO at $14/Sh
-
InMode Ltd. Announces Pricing of Initial Public Offering
-
Quanterix (QTRX) Announces Proposed $75M Public Offering of Common Stock
-
Quanterix Announces Proposed Public Offering of Common Stock
-
Canaccord Genuity Group Inc. Report on Voting Results
-
Canaccord Genuity Downgrades Hecla Mining (HL) to Sell
-
Prophix Software to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Synaptive Medical to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
-
Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
-
Canaccord Genuity Reiterates Buy Rating on Inseego Corp. (INSG)
-
Turning Point Therapeutics Inc. (TPTX) PT Raised to $53 at Canaccord Genuity
-
TransDigm (TDG) PT Raised to $575 at Canaccord Genuity
-
SolarEdge Technologies (SEDG) PT Raised to $78 at Canaccord Genuity
-
Retrophin (RTRX) PT Lowered to $38 at Canaccord Genuity
-
Renewable Energy Group (REGI) PT Lowered to $24 at Canaccord Genuity
-
Penumbra (PEN) PT Raised to $170 at Canaccord Genuity
-
Mistras Group (MG) PT Raised to $17 at Canaccord Genuity
-
HubSpot Inc (HUBS) PT Raised to $210 at Canaccord Genuity
-
Guardant Health (GH) PT Raised to $125 at Canaccord Genuity
-
DLH Holdings (DLHC) PT Lowered to $7 at Canaccord Genuity
-
Cubic (CUB) PT Raised to $74 at Canaccord Genuity
-
AxoGen, Inc. (AXGN) PT Lowered to $30 at Canaccord Genuity
-
Blue Apron (APRN) PT Raised to $8 at Canaccord Genuity
-
Form 8.3 - [accesso Technology Group plc] (CGWL)
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2020 Results
-
Viva Gold Corp Closes Private Placement
-
Aileron Therapeutics Reports Second Quarter 2019 Financial Results
-
vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences
-
Aptose Reports Results for the Second Quarter Ended June 30, 2019
-
Discovery 2019 Short Duration LP Initial Public Offering – Maximum $25,000,000
-
Everbridge to Present at Upcoming Investor Conferences
-
Teladoc Health to Participate in Upcoming Investor Conferences
-
Teladoc Health to Participate in Upcoming Investor Conferences
-
Vireo Health to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Indus Holdings, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference
-
inTEST to Present at Canaccord Genuity's 39th Annual Growth Conference
-
Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

